Breaking News Instant updates and real-time market news.

NKE

Nike

$87.41

0.06 (0.07%)

, LLY

Eli Lilly

$117.51

2.07 (1.79%)

16:20
04/23/19
04/23
16:20
04/23/19
16:20

Nike says John Lechleiter to retire from board of directors

Nike (NKE) announced that Dr. John C. Lechleiter, a director of the company since 2009 and former Chairman, President and Chief Executive Officer of Eli Lilly and Company (LLY), has decided to retire and will not stand for re-election to the board of directors at Nike at the September 2019 Annual Meeting of Shareholders. Lechleiter's decision to retire was due to scheduling conflicts with other boards on which he presently serves. Lechleiter will continue to serve as a Nike director until the 2019 Annual Meeting. He will be succeeded by Michelle Peluso, a director since 2014, as Chairperson of the Corporate Responsibility, Sustainability & Governance Committee of the Board.

NKE

Nike

$87.41

0.06 (0.07%)

LLY

Eli Lilly

$117.51

2.07 (1.79%)

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

NKE Nike
$87.41

0.06 (0.07%)

04/10/19
SBSH
04/10/19
INITIATION
Target $100
SBSH
Buy
Nike assumed with a Buy rating, $100 price target at Citi
Citi analyst Paul Lejuez assumed coverage of Nike from Kate McShane and kept a Buy rating on the shares. He raised his price target for the stock to $100 from $96. Nike is the dominant player in the global athletic footwear and apparel market, which is a "healthy and growing market buoyed by structural tailwinds," Lejuez tells investors in a research note.
04/10/19
SBSH
04/10/19
DOWNGRADE
Target $68
SBSH
Neutral
Foot Locker assumed with a Neutral from Buy at Citi
Citi analyst Paul Lejuez assumed coverage of Foot Locker (FL) from Kate McShane and downgraded the shares to Neutral from Buy. He also lowered his price target for the stock to $68 from $72. While Foot Locker has "tailwinds at its back" in North America with comps inflecting positively in Q4, the company still faces many of the same headwinds as other specialty retailers given its "significant" mall exposure and EBIT pressure from direct-to-consumer, Lejuez tells investors in a research note. He believes Nike's direct-to-consumer ambitions are a "secular headwind" for Foot Locker.
04/12/19
JEFF
04/12/19
NO CHANGE
JEFF
Under Armour discounts flat to down for 12th straight month, says Jefferies
Jefferies analyst Randal Konik says his firm's March webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is flat to down for the twelfth month in a row year-over-year, Jefferies analyst Randal Konik tells investors in a research note. Further, the webscrapes show Adidas's (ADDYY) percentage of product on discount is up for the twelfth month in a row year-over-year, adds the analyst. In addition, visits to Finish Line (FINL), Foot Locker (FL), and Under Armour websites reveal the HOVR, Project Rock, and Curry 6 are sold out in several sizes, indicating strong demand, says Konik. He believes Nike (NKE) continues to dominate Adidas in running in the U.S., with strength in Air VaporMax and Air Max 270. The analyst also thinks the data bodes well for Under Armour's's sales and margins in Q1.
04/18/19
PIPR
04/18/19
NO CHANGE
Target $30
PIPR
Overweight
Under Armour Q1 expectations 'at least achievable,' says Piper Jaffray
Piper Jaffray analyst Erinn Murphy says her work year-to-date indicates generally well controlled inventory across the domestic athletic industry. Currently, Under Armour (UAA) online clearance styles are down 19% year-over-year versus Nike's (NKE) down 5% and Adidas' (ADDYY) up 96%. The analyst believes industry competition "should remain rational" during 2019. Further, Q1 consensus expectations for Under Armour are "at least achievable" and management should maintain fiscal 2019 guidance, Murphy tells investors in a pre-earnings research note. The analyst this quarter has seen on-going traction with HOVR's footwear platform, broader focus with Under Armour's women's and a well-supported launch of Rush. She keeps an Overweight rating on Under Armour shares with a $30 price target.
LLY Eli Lilly
$117.51

2.07 (1.79%)

04/11/19
GUGG
04/11/19
DOWNGRADE
GUGG
Neutral
Guggenheim sees limited upside for Eli Lilly, downgrades to Neutral
As previously reported, Guggenheim analyst Seamus Fernandez downgraded Eli Lilly (LLY) to Neutral from Buy, stating that while he expects updates at the American Diabetes Association meeting to be broadly positive, he sees limited upside for the stock from current levels until Lilly's overall immunology portfolio and competition from Novo Nordisk's (NVO) semaglutide franchise is more fully understood. Though he still thinks Eli Lilly has "the best long-term growth profile in US Pharma," that growth is the broad consensus view, said Fernandez, who removed his price target on the stock but estimates the fair value to be in the range of $125-$135 per share.
04/11/19
04/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Chipotle (CMG) downgraded to Hold from Buy at Jefferies with analyst Andrew Barish saying after rallying 65% in Q1, Chipotle's valuation is full and reflects improved visibility for "powerful" same-store-sales and margin drivers. 2. Eli Lilly (LLY) downgraded to Neutral from Buy at Guggenheim with analyst Seamus Fernandez saying while he expects updates at the American Diabetes Association meeting to be broadly positive, he sees limited upside for the stock from current levels until Lilly's overall immunology portfolio and competition from Novo Nordisk's (NVO) semaglutide franchise is more fully understood. 3. U.S. Steel (X) downgraded to Underperform from Buy at BofA/Merrill with analyst Timna Tanners citing worse near-term U.S. market conditions than she anticipated. 4. Keurig Dr Pepper (KDP) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying she sees a negative risk-reward despite a "well telegraphed" Q1 earnings beat on strong pricing at heritage Dr. Pepper Snapple. 5. Waste Management (WM) downgraded to Hold from Buy at Stifel with analyst Michael Hoffman saying he factors in incrementally weaker paper prices and the impact of wet weather. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
PIPR
04/18/19
NO CHANGE
PIPR
Teva gains ground on Amgen in latest migraine survey, says Piper Jaffray
Following of survey of 99 neurologists done by his firm's partner Spherix Global Insights, Piper Jaffray analyst Christopher Raymond maintains an Overweight rating on Amgen (AMGN) and a Neutral rating on Teva Pharmaceutical (TEVA). The migraine survey indicates Eli Lilly's (LLY) Emgality is lagging and that Teva's Ajovy appears to be gaining ground on Amgen's Aimovig across numerous metrics, Raymond tells investors in a research note. While one data point does not a trend make, this move warrants close attention, especially given the increased significance assigned to Aimovig with respect to Amgen sentiment, says the analyst. Raymond, however, remains cautious on Teva shares given the" lack of clarity regarding when/where EBITDA will hit a trough." On the R&D side, the analyst notes that Overweight-rated Alder Biopharmaceuticals' (ALDR) eptinezumab "appears to be particularly top-of-mind among migraine specialists."
04/22/19
BMOC
04/22/19
NO CHANGE
Target $130
BMOC
Outperform
Eli Lilly price target lowered to $130 from $134 at BMO Capital
BMO Capital analyst Alex Arfaei lowered his price target on Eli Lilly to $130, saying the stock has underperformed along with its peers, and the news around its Tanezumab announced last week was "obviously negative". The analyst is keeping his Outperform rating however and believes that risk-reward on Eli Lilly is still "attractive" based on his "higher forecasts for Trulicity, Taltz, and Jardiance", as well as expectations around "improved margins". Arfaei adds that the company's upcoming REWIND data at the American Diabetes Association summit could be the "next major catalyst" for Eli Lilly shares.

TODAY'S FREE FLY STORIES

IQ

iQIYI

$18.29

1.21 (7.08%)

15:04
08/19/19
08/19
15:04
08/19/19
15:04
Options
iQiyi options imply 16.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

ADI

Analog Devices

$111.23

0.73 (0.66%)

15:00
08/19/19
08/19
15:00
08/19/19
15:00
Recommendations
Analog Devices analyst commentary  »

RBC says focus of Analog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

BIDU

Baidu

$104.30

7.65 (7.92%)

14:49
08/19/19
08/19
14:49
08/19/19
14:49
Options
Baidu options imply 14.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 04

    Sep

AVYA

Avaya

$12.27

-0.25 (-2.00%)

14:46
08/19/19
08/19
14:46
08/19/19
14:46
Periodicals
Avaya said to get bid from Mitel, Bloomberg says »

Avaya is weighing a bid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

TXG

10x Genomics

$0.00

(0.00%)

14:46
08/19/19
08/19
14:46
08/19/19
14:46
Syndicate
10x Genomics files for IPO, to list on Nasdaq under symbol 'TXG' »

10x Genomics filed an S-1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.05

0.085 (0.95%)

14:45
08/19/19
08/19
14:45
08/19/19
14:45
Periodicals
Ford to build two new midsize EV crossovers, Automotive News reports »

Ford Motor plans to build…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

HIIQ

Health Insurance Innovations

$17.42

-0.11 (-0.63%)

14:45
08/19/19
08/19
14:45
08/19/19
14:45
Options
Health Insurance Innovations call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

LAZ

Lazard

$34.27

1.14 (3.44%)

14:43
08/19/19
08/19
14:43
08/19/19
14:43
Periodicals
Lazard seen as top contender for role in Saudi Aramco IPO, Bloomberg says »

Lazard's success on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$41.98

4.93 (13.31%)

14:39
08/19/19
08/19
14:39
08/19/19
14:39
Upgrade
Weibo rating change  »

Weibo upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

FB

Facebook

$186.22

2.8 (1.53%)

14:33
08/19/19
08/19
14:33
08/19/19
14:33
Hot Stocks
Facebook says removing 'coordinated inauthentic behavior' from China »

Facebook's Nathaniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

GOOG

Alphabet

$1,201.56

24.62 (2.09%)

, GOOGL

Alphabet Class A

$1,203.66

24.97 (2.12%)

14:32
08/19/19
08/19
14:32
08/19/19
14:32
Periodicals
'Cyberpunk 2077' coming to Google Stadia, Verge reports »

Google (GOOG) announced…

GOOG

Alphabet

$1,201.56

24.62 (2.09%)

GOOGL

Alphabet Class A

$1,203.66

24.97 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

TRP

TC Pipeline

$48.70

0.3 (0.62%)

, SRE

Sempra Energy

$139.87

0.93 (0.67%)

14:31
08/19/19
08/19
14:31
08/19/19
14:31
Periodicals
Mexico near pact with pipeline builders, Reuters reports »

Mexico is close to…

TRP

TC Pipeline

$48.70

0.3 (0.62%)

SRE

Sempra Energy

$139.87

0.93 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$42.03

4.98 (13.44%)

14:30
08/19/19
08/19
14:30
08/19/19
14:30
Upgrade
Weibo rating change  »

Weibo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

NBRV

Nabriva Therapeutics

$2.13

-0.14 (-6.17%)

14:28
08/19/19
08/19
14:28
08/19/19
14:28
Hot Stocks
Breaking Hot Stocks news story on Nabriva Therapeutics »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 09

    Sep

LAZ

Lazard

$33.90

0.77 (2.32%)

14:24
08/19/19
08/19
14:24
08/19/19
14:24
Periodicals
Breaking Periodicals news story on Lazard »

Lazard seen as top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFGP

Ledyard Financial Group

$0.00

(0.00%)

14:21
08/19/19
08/19
14:21
08/19/19
14:21
Hot Stocks
Ledyard Financial Group announces 120K share repurchase plan »

Ledyard Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$41.69

1.11 (2.74%)

14:19
08/19/19
08/19
14:19
08/19/19
14:19
Hot Stocks
Twitter says will no longer accept advertising from state-controlled news media »

In a blog post, Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 20

    Aug

  • 24

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
08/19/19
08/19
14:17
08/19/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
08/19/19
08/19
14:16
08/19/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$48.17

2.66 (5.84%)

, TJX

TJX

$51.87

0.45 (0.88%)

14:11
08/19/19
08/19
14:11
08/19/19
14:11
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KSS

Kohl's

$48.17

2.66 (5.84%)

TJX

TJX

$51.87

0.45 (0.88%)

MDT

Medtronic

$103.90

1.17 (1.14%)

HD

Home Depot

$208.01

4.37 (2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

14:10
08/19/19
08/19
14:10
08/19/19
14:10
General news
Treasury Action: Treasuries remain heavy »

Treasury Action:…

CHE

Chemed

$434.70

4.53 (1.05%)

14:09
08/19/19
08/19
14:09
08/19/19
14:09
Hot Stocks
Chemed VP Michael Witzeman sells almost $2M in company shares »

Chemed VP Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
08/19/19
08/19
14:05
08/19/19
14:05
General news
Fed's Rosengren said he believes monetary and fiscal policy are already accommodative »

Fed's Rosengren said…

AAPL

Apple

$211.93

5.49 (2.66%)

, MSFT

Microsoft

$138.27

2.14 (1.57%)

14:02
08/19/19
08/19
14:02
08/19/19
14:02
Periodicals
Microsoft hires former head of Apple's Siri efforts, The Information says »

Microsoft (MSFT) has…

AAPL

Apple

$211.93

5.49 (2.66%)

MSFT

Microsoft

$138.27

2.14 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

RRR

Red Rock Resorts

$19.46

0.75 (4.01%)

, AES

AES Corp.

$15.46

0.25 (1.64%)

13:44
08/19/19
08/19
13:44
08/19/19
13:44
On The Fly
Fly Insider: Red Rock Resorts, Walgreen's among weeks notable insider trades »

Welcome to "Fly Insider,"…

RRR

Red Rock Resorts

$19.46

0.75 (4.01%)

AES

AES Corp.

$15.46

0.25 (1.64%)

GE

General Electric

$8.66

-0.13 (-1.48%)

MD

Mednax

$22.28

0.62 (2.86%)

CFR

Cullen/Frost

$85.74

0.95 (1.12%)

TWNK

Hostess Brands

$14.01

0.06 (0.43%)

WEN

Wendy's

$20.44

0.5 (2.51%)

PSA

Public Storage

$260.91

2.23 (0.86%)

AYX

Alteryx

$133.18

-0.57 (-0.43%)

WBA

Walgreens Boots Alliance

$51.40

1.3975 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 03

    Sep

  • 04

    Sep

  • 09

    Sep

  • 23

    Sep

  • 02

    Oct

  • 30

    Oct

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.